Health
ProSomnus® Sleep Technologies Announces Signing of Definitive Agreements for $30 Million of Convertible Notes
Financing will support Company's pending business combination and fund strategic growth initiatives SAN FRANCISCO, Aug. 26, 2022 /PRNewswire/ -- ProSomnus Sleep Technologies ("ProSomnus"), the leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today a...
2022-08-27 04:30
7867
Ascentage Pharma Announces 2022 Interim Results
SUZHOU, China and ROCKVILLE, Md. , Aug. 26, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its 2022 interim results. During the reporting p...
2022-08-27 00:47
13691
Waterdrop Releases User Family Insurance Report
BEIJING, Aug. 26, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, recently releasedthe User Family Security Report. According to the survey of the users...
2022-08-26 22:00
7779
First approval of Cadonilimab (PD-1/CTLA-4 bispecific) published in Drugs, a peer-reviewed medical journal
HONG KONG, Aug. 26, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso"), a biopharmaceutical company committed to the research, development, manufacturing and commercialization of either first-in-class or best-in-class therapies, announced a review article featuring onCadonilimab, a first-in-cla...
2022-08-26 20:00
2897
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe
Second region now open for enrolment for rare, rapidly progressive, neurodegenerative disease MELBOURNE, Australia and SAN FRANCISCO, Aug. 25, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing diseas...
2022-08-25 19:25
2489
Tigermed Reports 2022 Interim Result with Strong Financial Growth
HANGZHOU, China, Aug. 25, 2022 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its interi...
2022-08-25 19:05
3534
111, Inc. Announces Second Quarter 2022 Unaudited Financial Results
SHANGHAI, Aug. 25, 2022 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the second quar...
2022-08-25 14:18
2994
Alpha Biopharma Announces Completion of its EVEREST Phase II/III Clinical Study of Zorifertinib in Non-Small Cell Lung Cancer Patients with Central Nervous System Metastases
* Zorifertinib is a next generation EGFR-TKI with full Blood Brain Barrier penetration targeting EGFRm+ NSCLC patients with CNS metastases * Top-line data from the study are expected around the end of 2022 SHANGHAI, Aug. 24, 2022 /PRNewswire/ -- Alpha Biopharma, a developer of innovative drugs...
2022-08-25 10:00
1872
Asieris Pharmaceuticals (688176.SH) Issued 2022 Semi-Annual Report: Accelerated Global Clinical Development and Progressive Implementation of Its Integrated Diagnosis-Treatment Commercialization Strategy
SHANGHAI, Aug. 24, 2022 /PRNewswire/ -- Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, issued its 2022 semi-annual report today. As disclosed in...
2022-08-25 00:46
2492
CEO of Waterdrop Peng Shen was appointed as Vice-chairman of the Overseas Students and Chinese Committee of the Beijing Youth Federation
BEIJING, Aug. 24, 2022 /PRNewswire/ -- Mr. Peng Shen, Founder, Chairman, and CEO of Waterdrop, took office as the vice chairman of the Overseas Students and Chinese Committee of the Beijing Youth Federation (BYF). BYF is an organization that unites and gathers outstanding youth talents from all ...
2022-08-24 22:10
3529
MGI Wins IBO Design Gold Award for DNBelab C4 Pocket Single-Cell Lab
SHENZHEN, China, Aug. 24, 2022 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a global life science leader and innovator, has been awarded Gold by Instrument Business Outlook (IBO) at the 2022 IBO Design Awards for the outstanding design and functionality of its DNBelab C4 Pocket Single-Cell Lab. "MGI...
2022-08-24 22:05
2442
CARsgen 2022 Interim Results: Innovative CAR T-cell Technologies and Robust Pipeline
SHANGHAI, Aug. 24, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, has announced the 2022 Interim Results. Business Highlights * CT053: comple...
2022-08-24 20:50
2789
Jacobio Pharma Announces 2022 Interim Results
Investment in R&D increased 26.3% to RMB 221 million. Recorded revenue was RMB 54.7 million. Global development of KRAS G12C inhibitor and other clinical stage drug candidates accelerated. Development started in new pre-clinical stage drug candidates, such as iADC (immunostimulatory antibody-dr...
2022-08-24 00:32
3029
I-Mab Announces Share Purchase Plans by the Company and the Senior Management
GAITHERSBURG, Md. and SHANGHAI, Aug. 23, 2022 /PRNewswire/ -- I-Mab ("I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that it plans to implement share repurchases...
2022-08-23 21:13
3279
Clarity advances to cohort 3 of the CL04 trial of SARTATE™ in paediatric neuroblastoma
Highlights * Cohort 2 completed in participants with neuroblastoma who received therapy with67Cu SARTATE™ at a dose of 175MBq/kg body weight * No Dose Limiting Toxicities (DLTs) have been reported in cohort 1 and cohort 2 * Safety Review Committee (SRC) has recommended the trial continues w...
2022-08-23 21:04
2814
BIORCHESTRA appointed Dr. Gabriel Helmlinger (Ph.D., DABT) as Head of Translational and Clinical Pharmacology, Toxicology
BOSTON, Mass., Aug. 23, 2022 /PRNewswire/ -- BIORCHESTRA, headquartered in Daejeon,South Korea, appointed Dr. Gabriel Helmlinger (Ph.D., D.A.B.T.) as Vice-President, Head of Translational & Clinical Pharmacology, Toxicology. Dr. Helmlinger brings 25 years of drug research and clinical development...
2022-08-23 20:00
2069
AESOP Technology Wins Coveted Place in Mayo Clinic Platform_Accelerate Program to Build Better AI Model for Healthcare
SAN FRANCISCO, Aug. 22, 2022 /PRNewswire/ -- AESOP Technology
2022-08-23 00:00
2310
Waterdrop Joins the United Nations Global Compact
BEIJING, Aug. 22, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the
"Company" or "we") (NYSE: WDH
2022-08-22 22:00
2621
AVELOS THERAPEUTICS ANNOUNCES $8 MILLON SERIES A FUNDING ROUND
Seoul-Based Biotechnology Company to Use Financing for Expanding Oncology Drug Discovery and Development SEOUL, South Korea, Aug. 22, 2022 /PRNewswire/ -- Innovative biotechnology company specializing in new drug discovery and development, Avelos Therapeutics, has received a glowing endorsement ...
2022-08-22 20:00
1996
Ubie, Japanese Health-tech Startup, Raises $26.2 Million in Series C, $59.8 Million in Total
- Bringing Unprecedented Medical Experience by Strengthening Partnerships with Pharmaceutical Companies inJapan and U.S. to Build Medical Data Platform - TOKYO and SINGAPORE, Aug. 22, 2022 /PRNewswire/ -- Ubie, Inc., a healthcare AI startup with the mission "To develop a healthcare guide for ever...
2022-08-22 14:00
2145
Week's Top Stories
Most Reposted
Infobip recognized as RCS Business Messaging Leader by Juniper Research
[Picked up by 331 media titles]
2024-11-05 18:06
Mastercard goes OTP-free in APAC for faster, safer online transactions
[Picked up by 326 media titles]
2024-11-06 09:00Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00
Mastercard launches Pay Local, enabling Asia's digital wallet providers to process card payments from more than 2 billion Mastercard cardholders
[Picked up by 317 media titles]
2024-11-05 09:00XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
[Picked up by 277 media titles]
2024-11-07 11:34
Most Read
Mastercard goes OTP-free in APAC for faster, safer online transactions
2024-11-06 09:00
12399
Infobip recognized as RCS Business Messaging Leader by Juniper Research
2024-11-05 18:06
9442
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
8852